{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:15:39Z","timestamp":1777626939291,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"DOI":"10.7759\/cureus.107913","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:45:45Z","timestamp":1777423545000},"source":"Crossref","is-referenced-by-count":0,"title":["Hyperhomocysteinemia as a Common Denominator: Linking Posterior Subcapsular Cataract and Pulmonary Thromboembolism"],"prefix":"10.7759","author":[{"given":"Atishay","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuraj","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.021634","article-title":"Facts and recommendations about total homocysteine determinations: an expert opinion","volume":"50","author":"Refsum H","year":"2004","unstructured":"Refsum H, Smith AD, Ueland PM, et al.. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004, 50:3-32. 10.1373\/clinchem.2003.021634","journal-title":"Clin Chem"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.19.1.217","article-title":"Homocysteine metabolism","volume":"19","author":"Selhub J","year":"1999","unstructured":"Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999, 19:217-46. 10.1146\/annurev.nutr.19.1.217","journal-title":"Annu Rev Nutr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nm0496-386","article-title":"Homocysteine and vascular disease","volume":"2","author":"McCully KS","year":"1996","unstructured":"McCully KS. Homocysteine and vascular disease. Nat Med. 1996, 2:386-9. 10.1038\/nm0496-386","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2020\/44060.13662","article-title":"Hyperhomocysteinemia in acquired non-traumatic paralytic strabismus: a case series","volume":"14","author":"Sharma P","year":"2020","unstructured":"Sharma P, Vashist U. Hyperhomocysteinemia in acquired non-traumatic paralytic strabismus: a case series. J Clin Diagn Res. 2020, 14:10.7860\/JCDR\/2020\/44060.13662","journal-title":"J Clin Diagn Res"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.9.12.7672510","article-title":"Oxidative stress-induced cataract: mechanism of action","volume":"9","author":"Spector A","year":"1995","unstructured":"Spector A. Oxidative stress-induced cataract: mechanism of action. FASEB J. 1995, 9:1173-82.","journal-title":"FASEB J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2004.12.007","article-title":"Age-related nuclear cataract-oxidation is the key","volume":"80","author":"Truscott RJ","year":"2005","unstructured":"Truscott RJ. Age-related nuclear cataract-oxidation is the key. Exp Eye Res. 2005, 80:709-25. 10.1016\/j.exer.2004.12.007","journal-title":"Exp Eye Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2010.0300","article-title":"The ageing lens and cataract: a model of normal and pathological ageing","volume":"366","author":"Michael R","year":"2011","unstructured":"Michael R, Bron AJ. The ageing lens and cataract: a model of normal and pathological ageing. Philos Trans R Soc Lond B Biol Sci. 2011, 366:1278-92. 10.1098\/rstb.2010.0300","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon C","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J, et al.. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016, 149:315-52. 10.1016\/j.chest.2015.11.026","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603213341203","article-title":"Hyperhomocysteinemia as a risk factor for deep-vein thrombosis","volume":"334","author":"den Heijer M","year":"1996","unstructured":"den Heijer M, Koster T, Blom HJ, et al.. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996, 334:759-62. 10.1056\/NEJM199603213341203","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17911-2","article-title":"Age-related cataract","volume":"365","author":"Asbell PA","year":"2005","unstructured":"Asbell PA, Dualan I, Mindel J, Brocks D, Ahmad M, Epstein S. Age-related cataract. Lancet. 2005, 365:599-609. 10.1016\/S0140-6736(05)17911-2","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0886-3350(97)80040-5","article-title":"Epidemiology of cataract in childhood: a global perspective","volume":"23 Suppl 1","author":"Foster A","year":"1997","unstructured":"Foster A, Gilbert C, Rahi J. Epidemiology of cataract in childhood: a global perspective. J Cataract Refract Surg. 1997, 23 Suppl 1:601-4. 10.1016\/s0886-3350(97)80040-5","journal-title":"J Cataract Refract Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/09286580701423151","article-title":"Epidemiology of cataract: accomplishments over 25 years and future directions","volume":"14","author":"West S","year":"2007","unstructured":"West S. Epidemiology of cataract: accomplishments over 25 years and future directions. Ophthalmic Epidemiol. 2007, 14:173-8. 10.1080\/09286580701423151","journal-title":"Ophthalmic Epidemiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2016.0167","article-title":"Associations between methylenetetrahydrofolate reductase polymorphisms, serum homocysteine levels, and incident cortical cataract","volume":"134","author":"Tan AG","year":"2016","unstructured":"Tan AG, Kifley A, Mitchell P, et al.. Associations between methylenetetrahydrofolate reductase polymorphisms, serum homocysteine levels, and incident cortical cataract. JAMA Ophthalmol. 2016, 134:522-8. 10.1001\/jamaophthalmol.2016.0167","journal-title":"JAMA Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-008-0057-8","article-title":"Plasma homocysteine, folate and vitamin B(12) levels in senile cataract","volume":"23","author":"Sen SK","year":"2008","unstructured":"Sen SK, Pukazhvanthen P, Abraham R. Plasma homocysteine, folate and vitamin B(12) levels in senile cataract. Indian J Clin Biochem. 2008, 23:255-7. 10.1007\/s12291-008-0057-8","journal-title":"Indian J Clin Biochem"},{"key":"ref15","article-title":"Disorders of transsulfuration","author":"Mudd SH","year":"1995","unstructured":"Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. The Metabolic and Molecular Basis of Inherited Disease, 7th edition. Scriver CR, Beaudet AL, Sly WS, Valle D (ed): McGraw-Hill, Inc., New York; 1995. 1279-1327."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7135.894","article-title":"Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials","volume":"316","year":"1998","unstructured":"Lowering blood homocysteine with folic acid based supplements. meta-analysis of randomised trials. BMJ. 1998, 316:894-8. 10.1136\/bmj.316.7135.894","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2016.10.002","article-title":"Riboflavin, MTHFR genotype and blood pressure: a personalized approach to prevention and treatment of hypertension","volume":"53","author":"McNulty H","year":"2017","unstructured":"McNulty H, Strain JJ, Hughes CF, Ward M. Riboflavin, MTHFR genotype and blood pressure: a personalized approach to prevention and treatment of hypertension. Mol Aspects Med. 2017, 53:2-9. 10.1016\/j.mam.2016.10.002","journal-title":"Mol Aspects Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/486466-hyperhomocysteinemia-as-a-common-denominator-linking-posterior-subcapsular-cataract-and-pulmonary-thromboembolism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:45:46Z","timestamp":1777423546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/486466-hyperhomocysteinemia-as-a-common-denominator-linking-posterior-subcapsular-cataract-and-pulmonary-thromboembolism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.107913","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}